readthroughSign in
CompanyVYGRNasdaqLexington, MA

Voyager Therapeutics

Voyager Therapeutics develops AAV gene therapies for neurological diseases including Alzheimer's, Friedreich's ataxia, Parkinson's, and ALS using its TRACER platform to optimize brain delivery via intravenous administration.

SCHEDULE 13GNov 16Latest SEC filing
Nov 5Latest story